![]() |
| Anna Vlasits |
Seeing clearly is literally the life work of Anna Vlasits.
She is a young neurobiologist at the University of Illinois Chicago, studying how neurons work together in the retina of your eye to make vision possible.
"I'm a basic researcher," Vlasits said. "I'm brand new to UIC. I started my lab about a year ago."
Jane Miglo is a biology graduate student trying to cure ovarian cancer, which kills 140,000 women worldwide every year.
"My whole lab focuses on women's health," Miglo said. "It's already an area that's underfunded in comparison with the lethality of the disease."
Michael Schultz is a senior director at Portal Innovations, a biotech venture capital firm in the West Loop that operates shared lab space for startups. He knows firsthand how the most obscure research can blossom into practical applications.
"You don't know what's going to come from it," he said. "One example are these GLP1 drugs like Ozempic and Wegovy treating obesity. The first one was discovered in the saliva of a lizard, and now it's the biggest drug ever and hugely helping the obesity crisis."
None of the three are professional agitators. None have ever organized a public protest before. But the trio is part of the effort behind Chicago' s "Stand Up for Science" rally Friday at 12 p.m. at Federal Plaza, one of 32 rallies taking place nationwide to draw attention to the enormous damage caused by the Trump administration's wholesale slashing of National Institutes of Health research.
"I'm at the stage I'm just building," Vlasits said. "I got a startup fund from the University of Illinois to get going, but after that I need NIH funding. That is the way biomedical research happens in the United States, through this funding, and to have it get slashed and denigrated — it's a really scary place to be as a new researcher."
To continue reading, click here





